Moreover, it is significant to acknowledge that patients with CKD commonly experience lowered erythropoietin levels and exhibit heightened levels of prolactin, which ultimately leads to an increased incidence of anemia and decreased levels of hemoglobin. The gene discussed is EPO; the disease is chronic kidney disease.